PPARγ-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical development-Reference-Cited by-同舟云学术

PPARγ-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical development

Published:2018-12 Issue:22 Volume:26 Page:5870-5884
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Tanis Steven P.,Colca Jerry R.,Parker Timothy T.,Artman Gerald D.,Larsen Scott D.,McDonald William G.,Gadwood Robert C.,Kletzien Rolf F.,Zeller James B.,Lee Pil H.,Adams Wade J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference71 articles.

1. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes;Scoccio;Cell Metab,2014

2. What has prevented the expansion of insulin sensitizers?;Colca;Expert Opin Invest Drugs,2006

3. Insulin sensitizers in 2013: new insights for the development of novel therapeutics agents to treat metabolic diseases;Colca;Expert Opin Invest Drugs,2014

4. The TZD insulin sensitizer clue provides a new route into diabetes drug discovery;Colca;Expert Opin Drug Discovery,2015

5. Studies on antidiabetic agents. IV. Synthesis and activity of the metabolites of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (ciglitazone);Sohda;Chem Pharm Bull,1984

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential therapeutic medicines for renal fibrosis: Small-molecule compounds and natural products;Bioorganic Chemistry;2024-02

2. Thiazole: A versatile pharmacophore moiety;Current Trends in Pharmacy and Pharmaceutical Chemistry;2023-11-15

3. Insulin sensitizers in 2023: lessons learned and new avenues for investigation;Expert Opinion on Investigational Drugs;2023-09-02

4. Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones;Molecular Metabolism;2022-11

5. The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review;Archiv der Pharmazie;2022-06-17